On the eve of a Philadelphia Risperdal trial, Johnson & Johnson and Janssen Pharmaceuticals Inc. agreed to settle a lawsuit alleging a New York boy grew female breasts after...
Healthcare giant Johnson & Johnson (J&J) and its subsidiary Janssen Pharmaceuticals plan to ring in the new year with results from a seven year long study testing the effectiveness...
2016 has been a tough year healthcare giant Johnson & Johnson (J&J). The company lost several multimillion dollar baby powder cancer trials, lost a $70 million Risperdal trial, and...
The relationship between doctors and pharmaceutical companies has many restrictions. Pharmaceutical companies are not allowed to pay doctors kickbacks for prescribing certain medications. However, companies are allowed to pay...
The sixth Risperdal case to go to trial in the Philadelphia mass tort program against manufacturers Janssen Pharmaceuticals and Johnson & Johnson (J&J) has come to an abrupt end...
Just weeks after healthcare giant Johnson & Johnson (J&J) and its subsidiary Janssen Pharmaceuticals reached a confidential settlement with a Risperdal plaintiff, the companies are going to trial in...
The U.S. Judicial Panel on Multidistrict Litigation granted a coordinated docket for more than 100 lawsuits alleging the diabetes drug Invokana caused significant injuries. Cases are currently being transferred...
Since healthcare giant Johnson & Johnson (J&J) and its subsidiary Janssen Pharmaceuticals settled a Risperdal case in October, other plaintiffs in the Risperdal litigation hoped the settlement would set...
Janssen Pharmaceuticals and its parent company, Johnson & Johnson (J&J), have been fighting several dozen lawsuits concerning their diabetes medication Invokana. One lawsuit includes a Texas man who suffered...
While more than 7,000 Xarelto lawsuits have been consolidated in a multidistrict litigation (MDL) to the Eastern District of Louisiana, there are nearly 1,000 cases pending in a Philadelphia...
